Webcasts
Webinar Date/Time: Thu, Sep 14, 2023 11:00 AM EDT
Join the discussion on strategies to address characterization of protein therapeutics at the intact level during process development. Learn how an integrated icIEF-UV/MS workflow on the Intabio ZT system is changing the game for intact protein analysis.
Register Free: https://www.biopharminternational.com/bp_w/charge-variants
Event Overview:
In the development of biotherapeutics, genetic variations and post-translational modifications give each molecule a "personality”. Understanding these unique characteristics drives the development, manufacturability, and analytical methods used to monitor and control the quality attributes and testing requirements.
Join the discussion on strategies to address characterization of protein therapeutics at the intact level during process development. Learn more about the challenges in charge heterogeneity profiling, and how a disruptive approach using an integrated icIEF-UV/MS workflow with the Intabio ZT system is changing the game for scientists pushing the next generation of biotherapeutics forward.
Key Learning Objectives:
A disruptive approach for characterization of mAb charge variants in biopharmaceutical process development by icIEF-UV/MS
Intact-level multi-attribute monitoring of complex biologics
Characterization of a biopharmaceutical intensified process utilizing icIEF-UV/MS to quantify advanced glycation end products as a source of color
Who Should Attend:
Speakers:
Greg Adams PhD
Sr. Director Global Analytical Strategy & Development
FujiFilm Diosynth Biotechnologies
Anita P. Liu PhD
Associate Principal Scientist
Merck
Kristen Nields PhD
Senior Scientist
Janssen
Register Free: https://www.biopharminternational.com/bp_w/charge-variants